Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20228495 | 0.97 | ADH1A (0.35) | ADH1CADH1A | |
| SCHEMBL6062935 | 0.94 | ADH1A (0.39) | ADH1CADH1A | |
| SCHEMBL18878039 | 0.90 | — | — | |
| SCHEMBL21150311 | 0.75 | ADH1A (0.32) | ADH1CADH1A | |
| SCHEMBL12230787 | 0.73 | ADH1C (0.31) | ADH1CADH1A | |
| SCHEMBL25274904 | 0.73 | PHGDH (0.33) | ADH1CADH1A | |
| SCHEMBL29234274 | 0.72 | CYP1A2 (0.34) | ADH1CADH1A | |
| SCHEMBL11626082 | 0.71 | PHGDH (0.37) | ADH1CADH1A | |
| SCHEMBL810840 | 0.71 | PHGDH (0.37) | ADH1CADH1A | |
| SCHEMBL10453704 | 0.71 | ADH1C (0.35) | ADH1CADH1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220176363-A1 | PROCESS FOR OLIGOMERIZATION | DOW GLOBAL TECHNOLOGIES LLC (US) | 2022-06-09 | — | — | US | disclosed |
| US-10981156-B2 | Chromium complex and catalyst therefrom | DOW GLOBAL TECHNOLOGIES LLC (US) | 2021-04-20 | — | — | US | disclosed |
| US-10376869-B2 | Process for oligomerization | DOW GLOBAL TECHNOLOGIES LLC (US) | 2019-08-13 | — | — | US | disclosed |
| US-10357764-B2 | Phosphacycle compound and process for production thereof | DOW GLOBAL TECHNOLOGIES LLC (US) | 2019-07-23 | — | — | US | disclosed |
| US-20190210013-A1 | CHROMIUM COMPLEX AND CATALYST THEREFROM | DOW GLOBAL TECHNOLOGIES LLC (US) | 2019-07-11 | — | — | US | disclosed |
| US-10207262-B2 | Chromium complex and catalyst therefrom | DOW GLOBAL TECHNOLOGIES LLC (US) | 2019-02-19 | — | — | US | disclosed |
| US-20180154344-A1 | PROCESS FOR OLIGOMERIZATION | DOW GLOBAL TECHNOLOGIES LLC (US) | 2018-06-07 | — | — | US | disclosed |
| US-20180071725-A1 | CHROMIUM COMPLEX AND CATALYST THEREFROM | DOW GLOBAL TECHNOLOGIES LLC (US) | 2018-03-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180071725-A1 | CHROMIUM COMPLEX AND CATALYST THEREFROM | OXER1, LIG1, PICALM | ADH1C 2335/4885ADH1A 3067/4885 |
| US-10376869-B2 | Process for oligomerization | OXER1, NOD1, LIG1 | ADH1C 2213/4885ADH1A 3029/4885 |
| US-10981156-B2 | Chromium complex and catalyst therefrom | OXER1, LIG1, PICALM | ADH1C 2335/4885ADH1A 3067/4885 |
| US-10357764-B2 | Phosphacycle compound and process for production thereof | OXER1, PPIP5K2, IP6K1 | ADH1C 2869/4885ADH1A 3277/4885 |
| US-10207262-B2 | Chromium complex and catalyst therefrom | OXER1, LIG1, PICALM | ADH1C 2335/4885ADH1A 3067/4885 |
| US-20180154344-A1 | PROCESS FOR OLIGOMERIZATION | OXER1, NOD1, LIG1 | ADH1C 2213/4885ADH1A 3029/4885 |
| US-20220176363-A1 | PROCESS FOR OLIGOMERIZATION | OXER1, NOD1, LIG1 | ADH1C 2213/4885ADH1A 3029/4885 |
| US-20190210013-A1 | CHROMIUM COMPLEX AND CATALYST THEREFROM | OXER1, LIG1, PICALM | ADH1C 2335/4885ADH1A 3067/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.